Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1 percent of the population develops schizophrenia during their lifetime – more than 2 million Americans in a given year. Although it affects men and women with equal frequency, the disorder often appears earlier in men, usually in the late teens or early twenties, than in women, who are generally affected in the twenties to early thirties. People with schizophrenia often suffer terrifying symptoms that may leave them fearful and withdrawn. Their speech and behavior can be so disorganized that they may be incomprehensible or frightening to others. Available treatments can relieve many symptoms, but most people with schizophrenia continue to suffer some symptoms throughout their lives.
News items related to the topic: Schizophrenia
2015 Hobbs Discovery Grants announced
Innovation and an interest in “big data” characterize the three Nicholas Hobbs Discovery Grants awarded for 2015-16, which were announced by Elisabeth Dykens, Ph.D., Vanderbilt Kennedy Center (VKC) director and Annette Schaffer Eskind Chair.
Grants related to the topic: Schizophrenia
- Development of an M1 PAM Experimental Therapeutic fo Schizophrenia
PI: Conn, Jeffrey
People related to the topic: Schizophrenia
Ariel Deutch, Ph.D.
James G. Blakemore Chair and Professor of Psychiatry; Professor of Pharmacology; Director, National Parkinson Foundation Center of Excellence; Neurochemistry Faculty Service Coordinator, IDDRC Neuroscience Core D
Brad Grueter, Ph.D.
Assistant Professor of Anesthesiology, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences
Stephan Heckers, M.D.
William P. and Henry B. Test Professor of Psychiatry & Behavioral Sciences and Chair of the Department
Christine Konradi, Ph.D.
Professor of Pharmacology and Psychiatry & Behavioral Sciences
Sohee Park, Ph.D.
Gertrude Conaway Vanderbilt Professor of Psychology; Professor of Psychiatry & Behavioral Sciences and Medicine, Health & Society
Back to the topic index